Preclinical Evaluation of Technetium-99m-Labeled Somatostatin Receptor-Binding Peptides

Journal of Nuclear Medicine

Volumn 37, Issue 6, 1996, Pages 1016-1022

  Vallabhajosula, Shankar ^a   Moyer, Brian R ^b   Lister James, John ^b   McBride, Bill J ^b   Lipszyc, Helena ^b   Lee, Hiram ^b   Bastidas, Diago ^b   Dean, Richard T ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

Peptide; Receptor binding; Somatostatin receptor imaging; Technetium 99m; Tumor imaging

Indexed keywords

DIAGNOSTIC AGENT; PEPTIDE; SOMATOSTATIN RECEPTOR; TECHNETIUM;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL CULTURE; EXPERIMENTAL NEOPLASM; LEWIS RAT; METABOLISM; PANCREAS TUMOR; RAT; SCINTISCANNING; SYNTHESIS; TISSUE DISTRIBUTION;

ANIMALS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; PEPTIDES; RATS; RATS, INBRED LEW; RECEPTORS, SOMATOSTATIN; TECHNETIUM; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0030161551     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-731.
2. Brazeau P, Vale W, Burgus R, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973; 179:77-79.
3. Vale W, Brazeau P, Rivier C, et al. Somatostatin. Recent Prog Horm Res 1975;31: 365-397.
4. Yamada Y, Post SR, Wang K, et al. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract and kidney. Proc Natl Acad Sci USA 1992;89:251-255.
5. Rens-Domiano S, Law SF, Yamada Y, et al. Pharmacological properties of two cloned somatostatin receptors. Mol Pharmacol 1992;42:28-34.
6. Raynor K, Murphy WA, Coy DH, et al. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol Pharmacol 1993;43:838-844.
7. Raynor K, O'Carroll A-M, Kong H, et al. Characterization of cloned somatostatin receptors SSTR4 and SSTR5. Mol Pharmacol 1993;44:385-392.
8. Lamberts SWJ, Krenning EP, Reubi J-C. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Rev 1991;12:450-482.
9. Reubi J-C, Krenning E, Lamberts SWJ, Kvols L. Somatostatin receptors in malignant tissues. J Steroid Biochem Molec Biol 1990;37:1073-1077.
10. Eden PA, Taylor JE. Somatostatin receptor subtype gene expression in human and rodent tumors. Life Sci 1993;53:85-90.
11. Reubi JC, Schaer JC, Waser B, Mengod G. Expression and localization of somatostatin receptor SSTR1, SSTR2 and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 1994;54:3455-3459.
12. Bauer W, Briner U, Doepfner W, et al. SMS 201-995: a very potent and selective octapeptide analog of somatostatin with prolonged action. Life Sci 1982;31:1133-1140.
13. Pless J, Bauer W, Briner U, et al. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analog of somatostatin. In: Molinatti GM, Martinin L, Elsevier, eds. Endocrinology '85. New York, NY: 1986:319-333.
14. Murphy W, Lance VA, Moreau S, et al. Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin. Life Sci 1987;40:2515-2522.
15. Veber DF, Saperstein R, Nutt RF, et al. Science 1984;34:1371.
16. Veber DF, Saperstein R, Nutt RF, et al. A super active cyclic peptide analog of somatostatin. Life Sci 1984;34:1371-1378.
17. Bakker WH, Kreening EP, Breeman WAP, et al. In vivo use of a radiolabeled somatostatin analog: dynamics, metabolism and binding to somatostatin receptorpositive tumors in man. J Nucl Med 1991;32:1184-1189.
18. Krenning EP, Bakker WH, Kooij PPM, et al. Somatostatin receptor scintigraphy with ln-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with 1-123-Tyr-3-octreotide. J Nucl Med 1992;33:652-658.
19. Kvols LK, Brown ML, O'Connor MK, et al. Evaluation of a radiolabeled somatostatin analog (1-123 octreotide) in the detection and localization of carcinoid and islet cell tumors. Radiology 1993;187:129-133.
20. Lister-James J, McBride WJ, Moyer BR, et al. A structure-activity-relationship (SAR) study of somatostatin receptor-binding peptides radiolabeled with Tc-99m. J Nucl Med 1994;35:257P.
21. Cotton FA, Lippard SJ. Chemical and structural studies of the rhenium(V) oxyhalide complexes. I. Complexes from rhenium(III) bromide. Inorg Chem 1966;5:9-16.
22. Bylund DB, Yamamura HI. Methods for receptor birding. In: Yamamura HI, et al. eds. Methods in neurotransmitter receptor analysis. New York, NY: Raven Press; 1990:1-35.
23. 1]-octreotide for the detection of somatostatin receptor-positive tumors in rats. Life Sci 1991;49:593-1601.
24. Maina T, Stolz B, Albert H, et al. Synthesis, radiochemistry and biological evaluation of a new somatostatin analog (SDZ 219-387) labeled with technetium-99m. Eur J Nucl Med 1994;21:437-444.
25. Huang Z, He Y-B, Raynor K, et al. Main chain and side chain chiral methylated somatostatin analogs: syntheses and conformational analyses. J Am Chem Soc 1992;114:9390-9401.
26. 3 as a hippuran replacement. J Nucl Med 1986;27:111-116.
27. Rao TN, Adhikesavalu D, Camerman A, Fritzberg AR. Technetium (V) and rhenium (V) complexes of 2,3-bis(mercaptoacetamido)propanoate. Chelate ring stereochemistry and influence on chemical and biological properties. J Am Chem Soc 1990;112: 5798-5804.
28. 1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci 1991;49:1583-1591.
29. 99mTc. Radiology 1994;193P:300.